6.
Zhao C, Xu Y, Zhang Y, Tan W, Xue J, Yang Z
. Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases. Oncol Rep. 2013; 30(5):2027-34.
PMC: 3820619.
DOI: 10.3892/or.2013.2728.
View
7.
Preusser M, Berghoff A, Berger W, Ilhan-Mutlu A, Dinhof C, Widhalm G
. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer. Lung Cancer. 2013; 83(1):83-9.
DOI: 10.1016/j.lungcan.2013.10.004.
View
8.
Nam D, Jeon H, Kim S, Kim M, Lee Y, Lee M
. Activation of notch signaling in a xenograft model of brain metastasis. Clin Cancer Res. 2008; 14(13):4059-66.
DOI: 10.1158/1078-0432.CCR-07-4039.
View
9.
Turturici G, Tinnirello R, Sconzo G, Geraci F
. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol. 2014; 306(7):C621-33.
DOI: 10.1152/ajpcell.00228.2013.
View
10.
Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert W, Goldbrunner R, Herms J
. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med. 2009; 16(1):116-22.
DOI: 10.1038/nm.2072.
View
11.
Kim S, Kim J, Park E, Lee J, Lin Q, Langley R
. Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia. 2011; 13(3):286-98.
PMC: 3050871.
DOI: 10.1593/neo.11112.
View
12.
McDermott R, Gabikian P, Sarvaiya P, Ulasov I, Lesniak M
. MicroRNAs in brain metastases: big things come in small packages. J Mol Med (Berl). 2012; 91(1):5-13.
DOI: 10.1007/s00109-012-0971-3.
View
13.
Park E, Kim S, Kim S, Yoon S, Leem S, Kim S
. Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis. Proc Natl Acad Sci U S A. 2011; 108(42):17456-61.
PMC: 3198333.
DOI: 10.1073/pnas.1114210108.
View
14.
Kim S, Lee H, Kim M, Choi H, He J, Wu Q
. Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice. Clin Cancer Res. 2015; 21(20):4630-41.
PMC: 4780217.
DOI: 10.1158/1078-0432.CCR-14-3195.
View
15.
Neman J, Termini J, Wilczynski S, Vaidehi N, Choy C, Kowolik C
. Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc Natl Acad Sci U S A. 2014; 111(3):984-9.
PMC: 3903266.
DOI: 10.1073/pnas.1322098111.
View
16.
Brastianos P, Carter S, Santagata S, Cahill D, Taylor-Weiner A, Jones R
. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov. 2015; 5(11):1164-1177.
PMC: 4916970.
DOI: 10.1158/2159-8290.CD-15-0369.
View
17.
Chen G, Chakravarti N, Aardalen K, Lazar A, Tetzlaff M, Wubbenhorst B
. Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target. Clin Cancer Res. 2014; 20(21):5537-46.
PMC: 4216765.
DOI: 10.1158/1078-0432.CCR-13-3003.
View
18.
Hong X, Wang Q, Yang Y, Zheng S, Tong X, Zhang S
. Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin. Cancer Lett. 2011; 317(2):165-71.
DOI: 10.1016/j.canlet.2011.11.019.
View
19.
Cho W, Chow A, Au J
. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer. 2009; 45(12):2197-206.
DOI: 10.1016/j.ejca.2009.04.039.
View
20.
Chen E, Hewel J, Krueger J, Tiraby C, Weber M, Kralli A
. Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res. 2007; 67(4):1472-86.
DOI: 10.1158/0008-5472.CAN-06-3137.
View